• Log Out Log In
  • T. Rowe Price Health Sciences Fund (PRHSX)
    Ticker Symbol:
    Fund Status:
    Open to new Retail investors  /  Open to subsequent Retail investments
    Fund Composition
    Asset Allocation
    as of 06/30/2014
    Volatility and Other Measures
    as of 07/31/2014
    Beta 0.93
    Standard Deviation 15.09
    Price/Earnings Ratio (Domestic) 20.4
    Earnings Growth Rate (Domestic) 13.9
    Turnover Rate 31.5
    Median Market
    $22,458.03 Million
    10 Largest Holdings
    Represents 34.48 % of Total Net Assets
    View Holdings as of:
    Actavis plc
    Alexion Pharmaceuticals
    Allergan Inc/United States
    Biogen Idec
    Gilead Sciences
    Puma Biotechnology
    UnitedHealth Group
    As of 06/30/2014 the Health Sciences Fund had a total of 146 holdings.
    Sector Diversification
    as of 07/31/2014
    % of Total Net Assets
    Biotechnology 32.5%
    Services 25.2%
    Pharmaceuticals 21.7%
    Products & Devices 11.6%
    Life Sciences 5.6%
    Miscellaneous 2.8%
    See Glossary for additional details on all data elements.